Tuesday, 5 March, 2024
HomeQuick diagnosesMeningitis B vaccine

Meningitis B vaccine

US health regulators have granted [b]Novartis'[/b] meningitis B vaccine [b]Bexsero[/b] breakthrough therapy status. The company said it plans to file for US approval of Bexsero as early as the second quarter of this year. The vaccine already has approval in Europe, Canada and Australia and has been administered at several universities in the US to stop outbreaks of meningitis across campuses.

[link url=http://www.reuters.com/article/2014/04/07/us-novartis-usa-bexsero-idUSBREA3607V20140407] Reuters Health[/link]

MedicalBrief — our free weekly e-newsletter

We'd appreciate as much information as possible, however only an email address is required.